VR for Symptom Control and Wellbeing

NCT ID: NCT04821466

Last Updated: 2023-11-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-14

Study Completion Date

2022-09-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate the effect that a Virtual Reality experience can have on patient symptoms and wellbeing for palliative care and oncology inpatients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oncology End Stage Cancer Palliative Care Hematologic Malignancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Cohort interrupted time series study
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Virtual Reality Headset

VR headset, programmed with a selection of 7 wellbeing programs to identify if use will improve participants wellbeing

Group Type EXPERIMENTAL

Virtual Reality Headset to provide a Virtual Reality Experience

Intervention Type DEVICE

Participants will utilise a Virtual Reality experience for distraction therapy via a Virtual reality headset. Participants will wear the Virtual reality headset to be immersed in a multimedia experience.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual Reality Headset to provide a Virtual Reality Experience

Participants will utilise a Virtual Reality experience for distraction therapy via a Virtual reality headset. Participants will wear the Virtual reality headset to be immersed in a multimedia experience.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \> 18 years of age
* Inpatient at RCHT know to the palliative care team
* Able to consent
* Able to speak and understand the English language
* Able to use the virtual reality system
* Able to complete ESAS-r Questionnaire

Exclusion Criteria

* \<18 years of age
* Patient unable to consent
* Patient unable to speak English
* Unable to use the virtual reality system (e.g. visually impaired)
* Known Epilepsy or seizures or suspected predisposition to seizures (e.g. Brain metastasis)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Royal Cornwall Hospitals Trust

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Niall O Moon, BMBCh

Role: PRINCIPAL_INVESTIGATOR

Doctor

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Royal Cornwall Hospital

Truro, Cornwall, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Moon NO, Henstridge-Blows JR, Sprecher EA, Thomas E, Byfield A, McGrane J. 'Godrevy Project': virtual reality for symptom control and well-being in oncology and palliative care - a non-randomised pre-post interventional trial. BMJ Oncol. 2023 Dec 18;2(1):e000160. doi: 10.1136/bmjonc-2023-000160. eCollection 2023.

Reference Type DERIVED
PMID: 39886490 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021.RCHT.07

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Bringing Life to Those Near Death
NCT05466123 ENROLLING_BY_INVITATION NA
Virtual Reality at End-of-life
NCT06149429 COMPLETED NA
Empathy and Virtual Reality (VR)
NCT07314788 NOT_YET_RECRUITING NA